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Nonsense-mediated mRNA decay (NMD)
is an mRNA quality-control mechanism
that acts to degrade mRNAs harboring
premature termination codons (PTCs),
preventing the accumulation of truncated
proteins. Hug and Ca´ceres now find that
the DExH/D box RNA helicase DHX34 in-
teracts with several components of the
core NMDmachinery. It promotes a series
of molecular transitions that are a hall-
mark of conversion from the PTC recogni-
tion complex to the mRNA degradation
complex resulting in NMD activation.
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Nonsense-mediated decay (NMD) is a surveillance
mechanism that degrades aberrant mRNAs. A
complex comprising SMG1, UPF1, and the transla-
tion termination factors eRF1 and eRF3 (SURF)
is assembled in the vicinity of a premature termina-
tion codon. Subsequently, an interaction with UPF2,
UPF3b, and the exon junction complex induces
the formation of the decay-inducing complex
(DECID) and triggers NMD. We previously identified
the RNA helicase DHX34 as an NMD factor in
C. elegans and in vertebrates. Here, we investigate
the mechanism by which DHX34 activates NMD in
human cells. We show that DHX34 is recruited to
the SURF complex via its preferential interaction
with hypophosphorylated UPF1. A series of molecu-
lar transitions induced by DHX34 include enhanced
recruitment of UPF2, increased UPF1 phosphoryla-
tion, and dissociation of eRF3 from UPF1. Thus,
DHX34 promotes mRNP remodeling and triggers
the conversion from the SURF complex to the
DECID complex resulting in NMD activation.
INTRODUCTION
Nonsense-mediated mRNA decay (NMD) is a surveillance
pathway that eliminates mRNAs that contain premature termina-
tion codons (PTCs) preventing the synthesis of truncated pro-
teins (reviewed by Chang et al., 2007; Isken and Maquat, 2008;
Kervestin and Jacobson, 2012). This quality-control mechanism
has a central role in the control of gene expression because it
also targets for degradation a subset of naturally occurring tran-
scripts (Schweingruber et al., 2013). Regulation by NMDcan also
have an important role in the modulation of the phenotypic
outcome ofmany inherited genetic disorders that arise as conse-
quence of a frameshift or mutations that generate premature
termination codons (Bhuvanagiri et al., 2010). The basal NMD
machinery consist of seven conserved genes that were initially
identified by genetic screens in the nematode C. elegans
and were later shown to be involved in this pathway in otherCell Reorganisms, including insects, plants, and vertebrates. In hu-
mans, these are SMG1, UPF1, UPF2, UPF3, SMG5, SMG6,
and SMG7 (Nicholson et al., 2010). The NMD response is tightly
controlled by a negative-feedback regulatory mechanism that
controls the levels of core NMD factors in response to environ-
mental stresses (Huang et al., 2011; Yepiskoposyan et al., 2011).
In vertebrates, pre-mRNA splicing is coupled to NMD via the
exon junction complex (EJC), a multiprotein complex deposited
on exon junctions following pre-mRNA splicing that recruits
factors involved in NMD, mRNA export, and mRNA localization
(Le Hir et al., 2001; Lykke-Andersen et al., 2001). The ribosome
terminates prematurely at a PTC leaving downstream one or
more EJC complexes, which are not removed from the mRNA
and subsequently will recruit the NMD machinery. The essential
splicing factor CWC22 interacts with the EJC factor eIFA3 and
directly activates NMD by coupling splicing to EJC deposition
(Alexandrov et al., 2012; Barbosa et al., 2012; Steckelberg
et al., 2012).
The central NMD factor is the ATP-dependent RNA helicase,
UPF1, known as SMG-2 in nematodes, whose phosphorylation
is critical to trigger the NMD response. The SMG1c complex
comprising the protein kinase SMG1, a phosphoinositide 3-ki-
nase (PI3K)-like kinase, and the SMG8 and SMG9 subunits
phosphorylates UPF1 at multiple [S/T]Q motifs at its C-terminal
domain (reviewed by Yamashita, 2013). UPF1 is recruited to a
PTC via interactions with the translation release factors, eRF1
and eRF3, leading to the assembly of a complex termed SURF
that comprises SMG1 and UPF1, as well as eRF1 and eRF3.
The SURF complex interacts with a downstream EJC via interac-
tions with UPF2 and UPF3 proteins to form the decay-inducing
complex (DECID) that triggers UPF1 phosphorylation and the
dissociation of eRF1, 3 (Kashima et al., 2006). Subsequently,
phosphorylated UPF1 recruits additional NMD factors (SMG5,
SMG6, and SMG7) via their 14-3-3 domains that promote
direct interactions with phosphoresidues in UPF1 and further
rearrangements of this complex lead to mRNA degradation.
Whereas SMG5 and SMG7 bound to UPF1 provide a link to
mRNA decay (Jonas et al., 2013; Loh et al., 2013), SMG6 exhibits
an endonuclease activity that is required for NMD in Drosophila
and in vertebrates (Eberle et al., 2009; Huntzinger et al., 2008;
Wittkopp et al., 2009). Importantly, the precise mechanism that
controls the transition from the SURF to the DECID complex is
not fully understood.ports 8, 1845–1856, September 25, 2014 ª2014 The Authors 1845
Recently, additional trans-acting factors involved in the NMD
pathway have been uncovered, highlighting the complexity of
this surveillance mechanism. A proteomic approach searching
for novel SMG1 interactors led to the identification of two aden-
osine triphosphatases (AAA+) family proteins RuvB-like 1 and 2
(RUVBL1, RUVBL2) that promote SMG1 abundance and NMD
complex formation in a process involving their ATPase activities
(Izumi et al., 2010). A genome-wide RNAi screen in C. elegans
resulted in the identification of two additional NMD factors,
termed smgl-1 and smgl-2, that, unlike smg-1-7, are essential
for viability (Longman et al., 2007). These genes are highly
conserved throughout evolution and their human homologs,
NBAS (Neuroblastoma amplified sequence) and DHX34, func-
tion in the NMD pathway in human cells and also in zebrafish
(Anastasaki et al., 2011; Longman et al., 2007).
Here, we provide a thorough molecular characterization of the
role of DHX34 in the NMD pathway in human cells. We show that
DHX34 is an RNA binding protein that interacts with several NMD
factors, including UPF1 and its associated kinase, SMG1, as well
as with proteins required for RNA degradation. We also show
that recruitment of DHX34 to the SURF complex is required to
promote the interaction of UPF1 with UPF2, and this results in
UPF1 phosphorylation and release of eRF3. Altogether, these
data suggest that recruitment of DHX34 to the SURF complex
promotes UPF1 phosphorylation and triggers the conversion
from the SURF complex into the DECID complex resulting in
NMD progression and mRNA degradation.
RESULTS
DHX34 Is an RNA Binding Protein
Human DHX34 (DEAH box protein 34) belongs to the DExH/D
box family of proteins that use ATP hydrolysis to promote directly
or indirectly RNA-RNA unwinding, RNA-protein dissociation,
and protein-protein interactions (Jankowsky, 2011; Linder and
Jankowsky, 2011). It contains four domains, including one heli-
case domain (DExH/D) and three not well-characterized do-
mains (HELICc, HA2 and a C-terminal OB [Oligonucleotide/
oligosaccharide binding] fold), which are often found associated
with the helicase domain in this group of proteins (Figure 1A). The
highly conserved DExH/D helicase core consists of two re-
combinase A (RecA)-like helicase domains (domains 1 and 2),
comprising well-conserved sequence motifs (I–VI) that harbor
the binding sites for ATP, the ATPase activity as well as se-
quences responsible for RNA binding. The motif II contains the
DExH/D sequence, which gives the name to this protein family
(Figure 1A). First, we tested whether DHX34 directly binds to
mRNA. For this, we used an mRNA capture assay, which con-
sists of in situ UV crosslinking and denaturing oligo dT selection
to purify messenger ribonucleoprotein particles (mRNPs) from
HEK293T cells, as previously described (Pin˜ol-Roma and
Dreyfuss, 1992; Sanford et al., 2005). Affinity selection of mRNPs
by oligo dT cellulose clearly demonstrated that DHX34 is bound
to mRNA (Figure 1B). In order to determine the contribution of
ATP binding and/or hydrolysis, we mutated the lysine (K) residue
in the Walker A motif GXXXXGK(T/S) (K191S in motif I), which is
crucial for nucleotide binding, as well as the aspartate (D) residue
in the Walker B motif (D279A in motif II) that is required for1846 Cell Reports 8, 1845–1856, September 25, 2014 ª2014 The AuATP hydrolysis (Hanson and Whiteheart, 2005) (Figure 1A) and
analyzed the ability of these DHX34 mutant proteins to bind to
RNA. Neither of themutations disrupted RNA binding (Figure 1C)
despite being highly overexpressed (Figure S1A). We observed
that the K191S mutation that abrogates ATP binding showed
similar mRNA binding compared to the wild-type protein. By
contrast, the point mutation in the conserved aspartate residue
of motif II (D279A), which abrogates ATP hydrolysis, displayed
increased binding to mRNA. We also confirmed the binding of
endogenous DHX34 protein by performing immunoprecipita-
tions of UV-crosslinked RNA-protein complexes (Figure S1B).
Altogether, these results demonstrate that DHX34 binds RNA
directly and that a defect in ATP hydrolysis results in increased
mRNA association suggesting that this might be required for
the release of DHX34 from mRNA (Figure 1C), as has been
seen in other instances (Henn et al., 2010; Liu et al., 2008).
DHX34 Interacts with NMD Effectors
In order to dissect the role of DHX34 in the NMD pathway, we
used a combination of immunoprecipitation (IP)-mass spec-
trometry with a candidate approach in which we tested for
interactions with known NMD components. First, we immuno-
purified endogenous DHX34 from HEK293T cells and deter-
mined the associated proteins using mass spectrometry. This
analysis was carried out in the absence of RNases in order to
identify the composition of DHX34 mRNPs. For all subsequent
validation experiments, we treated the lysates with RNases
(see below). This experiment resulted in the identification of
several RNA binding proteins, including proteins linked to the
NMD pathway, and many other RNA processing events (Figures
S2A and Table S1). From this list, we validated five interactors
that have been previously described to function in NMD: the
core factor UPF1, the RNA helicase MOV10 (Gregersen et al.,
2014), the EJC component, eIF4A3, the mRNA Cap-binding
protein, CPB80, and the 50 to 30 exonuclease XRN2. We
transiently expressed FLAG-tagged DHX34 and following anti-
FLAG Immunoprecipitation in the presence or absence of
RNases, we analyzed the corresponding proteins by western
blot analysis. A control for the activity of RNase in the degrada-
tion of cellular RNAs is provided (Figure S2E). We observed that
DHX34 interacts in an RNA-independent manner with UPF1,
MOV10, XRN2, and eIF4A3, whereas its interaction with
CBP80 is RNA dependent (Figure 2A). We confirmed the inter-
action of DHX34 with UPF1 by showing the copurification of
endogenous DHX34 protein with epitope-tagged FLAG-UPF1
in an RNA-independent manner (Figure S2B) as well as by the
coimmunoprecipitation of endogenous DHX34 and UPF1
proteins (Figure S2C). To better understand the function of
DHX34 in NMD, we tested the interaction of DHX34 with known
NMD factors and RNA degradation factors, in the presence or
absence of RNases. We found that FLAG-tagged DHX34
coimmunoprecipitated the NMD factors SMG1, SMG7, SMG9,
SMG6, and UPF3a in an RNA-independent manner (Figures
2B and S2D). We could also detect RNA-dependent interac-
tions of DHX34 with UPF3b and the EJC component, MLN51
(Figure S2D). No interaction could be detected with PABP1 or
with the eukaryotic release factor eRF3 (Figure 2B), nor with
the NMD core factor UPF2 (Figure S2D). By contrast, we foundthors
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Figure 1. DHX34 Is an RNA Binding Protein
(A) Cartoon depicting the functional domains of DHX34. The lower panel depicts the motifs present in the DExH/D box helicase domain, as well as two mutations
in individual domains responsible for ATP binding and ATP hydrolysis, respectively (shown with asterisks).
(B) HEK293T cells transiently transfectedwith FLAG-DHX34were subjected to in situ UV crosslinking, followed by purification ofmRNP complexes usingOligo dT
chromatography under denaturing conditions. Lanes 1–4 (0.7% Input) contain extracts prior to Oligo dT selection, whereas lanes 5–8 (20% Oligo dT selected)
contain purifiedmRNPs eluted fromOligo dT cellulose. Anti-FLAGwas used to visualize the presence of DHX34 bound to purified mRNPs in western blot assays.
An antibody that reacts with poly (A) binding protein (PABP1) was used as a purification control, whereas antitubulin served as a negative control.
(C) The RNA binding ability of the DHX34mutant proteins depicted in (A) was assayed by anmRNA capture assay, as described in (B). The lower panel shows the
ratio of oligo dT cellulose purified FLAG-DHX34 protein over PABP1 from at least two independent experiments.a positive interaction for these factors with FLAG-UPF1, as
previously reported (reviewed by Mu¨hlemann et al., 2008)
(Figures 2B and S2B). Under these conditions PABP1 interacts
with UPF1 only in the presence of RNA. We also detected inter-
actions of DHX34 with RNA degradation factors such as
the exonuclease XRN1, the exosome component DIS3, and
the decapping enzyme DCP1, all of them independently of the
presence of RNA (Figure 2B). In summary, a combination of
an IP-mass spectrometry approach with a candidate analysis
revealed that DHX34 interacts with several components of the
NMD pathway, including core NMD factors as well as RNA de-
grading components (summarized in Figure S2F).Cell ReDHX34 Interacts with UPF1 Directly and Preferentially
Associates with SURF Complexes
Next, we probed for a direct interaction of UPF1 and DHX34 by
coincubating FLAG-DHX34 purified from HEK293T cells with re-
combinant UPF1 protein. We found that FLAG-DHX34 was able
to pull-down recombinant UPF1 protein (Figure 3A). This strongly
suggests that DHX34 andUPF1 interact directly, even thoughwe
cannot formally exclude that this interaction could be mediated
through the presence of a copurified bridging protein. FLAG-
DHX34 interaction with UPF1 was still observed upon RNase
treatment (Figure S3A); however, we could not observe any bind-
ing of UPF1 to the unrelated protein FLAG-KAT8 under the sameports 8, 1845–1856, September 25, 2014 ª2014 The Authors 1847
A B Figure 2. DHX34 Interacts with NMD
Effectors
(A) Cells were transiently transfected with FLAG-
DHX34. Anti-FLAG IPs were performed in the
presence or absence of RNase A. Inputs (1%) and
anti-FLAG IPs (25%) were subjected to western
analysis and probed for the indicated proteins.
(B) Immunoprecipitation of transiently transfected
FLAG-DHX34 and FLAG-UPF1 from HEK293T
cells in the absence or presence of RNase A.
Inputs (0.5%) and anti-FLAG IPs (20%) were
subjected to western analysis using the indicated
antibodies.conditions (Figure S3A). Furthermore, we noticed that, whereas
T7-tagged DHX34 binds very strongly to purified full-length
FLAG-UPF1, it has only a very weak affinity for UPF2 and
UPF3b (Figure S3B, compare lanes 9, 11, and 14). We next
analyzed the functional domains in DHX34 that are required
for its interaction with endogenous UPF1 by overexpressing
T7-tagged DHX34 (wild-type and deletion mutant proteins). We
observed that deletion of the entire HrpA (DHrpA) region abol-
ished binding to UPF1, whereas DDExH/D displayed a reduced
interaction. All the remaining deletion mutants could still interact
with UPF1 (Figure 3B). This was recapitulated in vitro by coincu-
bation of purified T7-DHX34 (wild-type andmutant proteins) with
recombinant UPF1 proteins, which again showed a reduced
interaction of T7-DHX34DHrpA with UPF1 (Figure S3C, compare
lanes 13 and 16). We next used immunoprecipitation assays of
HEK293T cells coexpressing FLAG-UPF1 (wild-type and dele-
tion mutants) and T7-tagged DHX34 to delineate the domains
of UPF1 that are required for its interaction with DHX34. UPF1
consists of an N-terminal cysteine-histidine domain (CH) regula-
tory domain, which is bound by UPF2 (Cheng et al., 2007; Clerici
et al., 2009; Kadlec et al., 2006), a central helicase domain and a
C-terminal tail that contains several S/T Q (SQ) motifs that are
phosphorylated by SMG1 (Ohnishi et al., 2003). DHX34 showed
a slightly reduced interaction with the deletion mutants lacking
the N-terminal tail (DN) and the globular CH domain (DCH) (Fig-
ure 3C, compare lanes 8, 9, and 11). Most interestingly, the
deletion lacking the C terminus (DCT) comprising the SMG1-
phosphorylation sites showed an increased association with
DHX34 compared to the wild-type protein, which is suggestive
of DHX34 binding to nonphosphorylated UPF1 (Figure 3C,
compare lanes 8 and 10). UPF1 (wild-type and deletion mutants)
were expressed at similar levels to the endogenous protein (Fig-
ure S3D). The observation that DHX34 preferentially binds to
UPF1 lacking its phosphorylated C terminus raised the question
whether DHX34 binds to hypophosphorylated UPF1. Because
UPF1 phosphorylation is a later step in NMD activation (Kashima
et al., 2006), we wanted to investigate the temporal sequence
during which DHX34 is recruited to UPF1-containing NMD com-1848 Cell Reports 8, 1845–1856, September 25, 2014 ª2014 The Authorsplexes. We took advantage of a series of
UPF1 mutant proteins that affect distinct
functions of this protein. First, we
observed that the FLAG-tagged K498A
substitution mutant, which affects anATP binding residue and abolishes the ATPase activity of UPF1
(Chenget al., 2007) and is hyperphosphorylated displayed similar
binding to T7-tagged DHX34 as the wild-type FLAG-UPF1 pro-
tein (Figure 3D, lanes 6 and 8). By contrast, the C126S mutation
in UPF1 that prevents its interaction with UPF2 and consequently
freezes the surveillance complex (Kashima et al., 2006; Weng
et al., 1996) displayed a strong enrichment of DHX34 binding
compared to wild-type UPF1 (Figure 3A, compare lanes 6
and 7). This suggested that DHX34 is preferentially recruited to
the SURF complex, where UPF1 is hypophoshorylated. In agree-
ment with this, a different UPF1 mutant protein (G495R/G497E),
which is hyperphosphorylated (Figure S3E, lanes 5–8) probably
due to a helicase defect similar to the K498A substitution (Page
et al., 1999), showed even reduced DHX34 association (Fig-
ure S3E). Altogether, these experiments strongly suggest that
DHX34 is preferentially recruited to the SURF complex.
DHX34 Promotes UPF1 Phosphorylation
Because we detected interactions of DHX34 with UPF1 and with
its protein kinase SMG1 and found that DHX34 binds preferen-
tially to the SURF complex, we next tested whether DHX34
affects UPF1 phosphorylation. We immunoprecipitated FLAG-
tagged UPF1 and analyzed its phosphorylation status in the
presence or absence of DHX34 using a phospho-(Ser/Thr)
ATM/ATR substrate antibody. We found that UPF1 phosphoryla-
tion increased upon overexpression of T7-DHX34 (Figure 4A,
compare lanes 7 and 8). Conversely, small hairpin RNA
(shRNA)-mediated depletion of DHX34 resulted in a marked
decrease in UPF1 phosphorylation (Figure 4B). The effect on
UPF1 phosphorylation correlated well with the level of DHX34
overexpression (Figures S4A and S4B), and a reduction in
the phosphorylation of endogenous UPF1 protein was also
observed upon DHX34 depletion (Figure 4C). Importantly, the
levels of UPF1 phosphorylation were rescued upon the expres-
sion of an shRNA-resistant wild-type DHX34 construct, but not
by the ATPase-deficient DHX34 mutants (K191S or D279A),
which affect ATP binding or ATP hydrolysis, respectively (Fig-
ure 4D). Next, we investigated whether DHX34 has a direct effect
on UPF1 phosphorylation. For this, we performed in vitro kinase
assays with purified recombinant SMG1 protein and monitored
its kinase activity on SMG1 autophosphorylation (Morita et al.,
2007) as well as on UPF1, in the presence or absence of added
DHX34. We noticed that the addition of purified DHX34 had no
effect on the SMG1 kinase activity on neither of the substrates
(Figure S4C). These experiments suggest that the effect of
DHX34 on UPF1 phosphorylation is not direct and could reflect
that DHX34 activates a molecular event that indirectly triggers
UPF1 phosphorylation (see below).
DHX34 Promotes Interaction of UPF1 with UPF2 and the
EJC Complex
The NMD pathway can be activated via different branches that
differ in their dependence on the NMD factors UPF2, UPF3b,
and EJC components (Chan et al., 2007; Gehring et al., 2005;
Ivanov et al., 2008); however, they all require UPF1 to activate
NMD (Figure 5A). Because DHX34 preferentially associates
with SURF complexes and promotes UPF1 phosphorylation,
we tested the formation of the DECID complex in the absence
of DHX34. We observed a reduced interaction of UPF1 with
UPF2 and with eIF4A3 in cells depleted of DHX34 (Figure 5B;
compare lanes 5 and 6 with lanes 7 and 8). By contrast, no
reduced interaction was observed for SMG1, SMG7, XRN2,
whereas a slightly increased binding of SMG9 was observed
(Figure S5A). Whereas expression of an shRNA-resistant wild-
type DHX34 restored the interaction of UPF1 with UPF2
and with eIF4A3 (Figure 5C, lane 10), the expression of the
ATPase-deficient DHX34 mutants (K191S or D279A) failed to
achieve this (Figure 5C, lanes 11 and 12). Importantly, we noticed
that upon depletion of DHX34 the association of endogenous
UPF2 with UPF1 was drastically reduced (Figure 5D). In order
to delineate the branch of the NMD pathway that is affected by
DHX34, we took advantage of a series of UPF1 mutant proteins
(C126S, LECY181-184VRVD, and VV204-205DI), all of which
have lost UPF2 binding (Figure 5E). An important functional
distinction is that, although the first two UPF1 mutants are
inactive in NMD, the VV204-205DI mutant can use the UPF3b
alternative branch of the NMD pathway (Ivanov et al., 2008).
We found that DHX34 preferentially binds UPF1 C126S and
LECY181-184VRVD mutant proteins (Figure 5E). However,
we could not observe an increased binding of DHX34 to the
VV204-205DI mutant (Figure 5E, compare lanes 7–10), suggest-
ing that DHX34 does not affect the UPF3b-dependent branch of
NMD. This is supported by the fact that DHX34 does not influ-
ence UPF1 binding to UPF3b (Figure 5B). To further dissect
the involvement of DHX34 in different NMD branches, we per-
formed gene expression analysis using Agilent microarrays
of HeLa cells individually depleted of DHX34, UPF1, UPF2, or
UPF3b. We clearly observed that DHX34 and the core NMD fac-
tors UPF1, UPF2, and UPF3b show a significant positive corre-
lation in the regulation of endogenous RNA targets (p value for
all comparisons <2.2 3 1016) (Figure S5B). Next, we focused
on genes upregulated upon depletion of UPF1 and DHX34 (n =
800), UPF2 (n = 896), or UPF3b (n = 310). We defined these as
bona fide NMD targets. From this analysis, we conclude that
DHX34 coregulates a significant proportion of RNA targets with
UPF2 and UPF1 (n = 277) and with UPF3b and UPF1 (n = 166)Cell Re(Figure S5C). Together, with the biochemical evidence pre-
sented above, this would suggest that DHX34 is not involved in
an alternative branch of the NMD pathway; rather, it seems to
activate the canonical NMD pathway.
DHX34 Triggers the Conversion of the SURF to the
DECID Complex
Results presented so far are compatible with a role for DHX34 in
the active remodeling of the SURF complex promoting its transi-
tion to the DECID complex. This is supported by the finding that
overexpression of DHX34 results in the release of eRF3 from
UPF1 complexes, which is a hallmark of this transition (Figure 6A,
lanes 7 and 8). By contrast, the interaction of UPF1 with SMG1
was not impaired (Figure 6A); however, a decreased recruitment
of SMG9, a subunit of the SMG1c complex, was also observed
(Figure 6A) as well as the DHX34-dependent recruitment of
UPF2 and eIF4A3 (Figures 5 and 6A). Interestingly, the interac-
tion of UPF1 with eIF3A or CBP80 was not affected (Figure S6A),
strongly suggesting that DHX34 does not activate NMD by either
promoting translational repression (via a phospho-Upf1-eIF3
interaction) (Isken et al., 2008) or by stimulating the interaction
of UPF1 with CBP80 (Hwang et al., 2010). Conversely, in the
absence of DHX34 we observed an increased association of
eRF3 with UPF1 (Figure 6B, compare lanes 6 and 8). We previ-
ously failed to detect an interaction of wild-type DHX34 with
the translation release factor eRF3 (Figure 2B). We reasoned
that if eRF3 release is triggered upon DHX34 ATP hydrolysis,
we would be able to detect the DHX34-eRF3 interaction using
the catalytically inactive mutants of DHX34. Thus, we depleted
endogenous DHX34 and coexpressed shRNA-resistant T7-
tagged DHX34 (wild-type and the ATPase mutants K191S and
D279A) with FLAG-eRF1 (Figure 6C) or FLAG-eRF3 (Figure 6D).
In agreement with previous results (Figure 2B), wild-type
T7-DHX34, although expressed at a high level, failed to interact
with eRF1 and eRF3. Interestingly, we could detect the two
ATPase mutants of DHX34 associated with eRF1 (Figure 6C)
and eRF3 (Figure 6D). By contrast, we could not find any differ-
ences in the binding of the two ATPase mutants to any other
member of the SURF complex. For instance, we found that
SMG1 coimmunoprecipitated with T7-tagged DHX34 (wild-
type or mutants) to a similar extent (Figure S6B). Furthermore,
DHX34 (wild-type and mutants) showed preferential binding to
the C126S and LECY181-184VRVD UPF1 mutants that freeze
the SURF complex (Figures S6C–S6E).
Altogether, these results suggest that DHX34 supports the
transition from SURF to DECID resulting in UPF1 phosphoryla-
tion and release of the eRFs from the PTC resulting in targeting
of the faulty mRNA for degradation. In summary, this work pro-
vides a mechanistic characterization of the role of the RNA heli-
case DHX34 in mRNP remodeling leading to activation of NMD.
DISCUSSION
We previously found that DHX34 acts in concert with core NMD
factors to coregulate a significant number of endogenous RNA
targets in C. elegans, zebrafish, and human cells (Anastasaki
et al., 2011; Longman et al., 2007, 2013). Here, we provide a
mechanistic analysis of the role of DHX34 in the NMD pathwayports 8, 1845–1856, September 25, 2014 ª2014 The Authors 1849
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Figure 3. DHX34 Interacts with UPF1 and Preferentially Associates with SURF Complexes
(A) Interaction between purified FLAG-DHX34 and recombinant UPF1 proteins, which were mixed in a 1:1 ratio and pulled down using anti-FLAG beads. FLAG-
DHX34 was purified from HEK293T cells under stringent conditions, whereas recombinant UPF1 protein was purified from bacteria. Inputs (5%) and pull-down
fractions (20%) were analyzed after SDS-PAGE by Coomassie staining or western blots, with the indicated antibodies.
(B) The upper panel shows the domain structure organization of DHX34, already described on Figure 1A. Immunoprecipitation of transiently transfected T7-
DHX34 (wild-type or deletion mutants) from HEK293T cells was performed in the presence of RNase A. Inputs (0.5%) and anti-FLAG IPs (20%) were subjected to
western blot analysis using the indicated antibodies. The level of overexpression of wild-type T7-DHX34 was determined by comparison with levels of
endogenous DHX34 protein, which was probed with a specific antibody (input panel). The lower band corresponds to DHX34, whereas an asterisk above DHX34
indicates an unspecific band.
(C) The upper panel shows the domain organization of UPF1 and the corresponding deletion mutants. FLAG IPs from cells transiently cotransfected with FLAG-
UPF1 (wild-type or deletion mutants) and T7-DHX34 were performed in the presence of RNase A. Inputs (0.5%) and anti-FLAG IPs (20%) were subjected to
western blot analysis using the indicated antibodies.
(legend continued on next page)




Figure 4. DHX34 Promotes UPF1 Phosphor-
ylation
(A) HEK293T cells were transiently transfected
with FLAG-UPF1 in the absence or presence of
cotransfected T7-DHX34. Inputs (0.5%) and anti-
FLAG IPs (20%) were probed with the indicated
antibodies. Phosphorylated UPF1 was detected
with a phospho-(Ser/Thr) ATM/ATR substrate
antibody. The Phospho-FLAG-UPF1 signal was
normalized to the levels of UPF1 recovered in the
IP. A quantification of relative levels and SDs of
the western blot signals from three independent
experiments are shown (right panel).
(B) HEK293T cells depleted of DHX34 with a
specific shRNA (with empty vector plasmids or
an shRNA targeting Luciferase (LUCIF) used as
negative controls) for 4 days were then transfected
with FLAG-UPF1 or an empty vector control and
immunoprecipitated 3 days later. Phosphorylation
levels of UPF1 were determined as described
above.
(C) Detection of phospho- UPF1 was as described
above despite that cells were transfected with
DHX34 shRNA or an shRNA targeting Luciferase
() and endogenous UPF1 was immunopurified
5 days later. Inputs (0.5%) and IPs (20%) were
probed with the indicated antibodies. Asterisks
indicate phosphorylated proteins (distinct from
UPF1) recognized with phospho-(Ser/Thr) ATM/
ATR substrate antibodies in the input samples.
Depletion of DHX34 is shown on the right, with the
top band corresponding to DHX34, whereas the
asterisks below indicate unspecific bands. Quan-
tification of the western blot signal and SDs from
two independent experiments are shown (right
panel).
(D) HEK293T cells depleted of DHX34 with specific
shRNA or transfected with an shRNA targeting
Luciferase () were cotransfected with FLAG-
UPF1 and shRNA-resistant (R) wild-type T7-
DHX34 or ATPase-deficient version (K191S or
D279A). Phosphorylated UPF1 was detected as
described above. Asterisks indicate phosphory-
lated proteins (distinct from UPF1) that were also
recognized with phospho-(Ser/Thr) ATM/ATR
substrate antibodies in the input samples. A
quantification of the western blot signal and SDs
from three independent experiments are shown
(right panel).in human cells. A combination of a mass spectrometry interac-
tome with a gene candidate approach revealed interactions of
DHX34 with mRNA degradation factors, as well as with the cen-
tral NMD factor UPF1 and its kinase SMG1 (Figures 2 and S2).
Despite being central for the NMD process, there is limited infor-
mation on how the protein kinase SMG1 is activated and how the
transition from the SURF to the DECID complex is achieved. The
SMG8 and SMG9 subunits recruit SMG1 to the SURF complex(D) DHX34 binds preferentially nonphosphorylated UPF1. The upper panel shows
binding domain of UPF1 (K498A) or in the UPF1 C126Smutant, indicated with a ve
DHX34 in HEK293T cells. Input (0.5%) and anti-FLAG IPs (20%) were subjected
UPF1 (phospho-FLAG-UPF1), anti-FLAG IPs were probed with a phospho-(Ser/T
Cell Reand allosterically inhibit the kinase activity of SMG1 (Ferna´ndez
et al., 2011; Yamashita et al., 2009). The subsequent interaction
of the C terminus of SMG1 and UPF2 are believed to induce the
dissociation of SMG8 and activation of SMG1 (Arias-Palomo
et al., 2011; Yamashita et al., 2009).
DHX34 is recruited to the SURF complex via its preferential
interaction with hypophosphorylated UPF1 and subsequently
promotes UPF1 phosphorylation concomitantly with a disruptionthe domain structure of UPF1, with the point mutations introduced in the ATP
rtical bar. FLAG-UPF1 (wild-type ormutants thereof) was coexpressedwith T7-
to western blot analysis for the indicated proteins. To detect phosphorylated
hr) ATM/ATR substrate antibody.




Figure 5. DHX34 Promotes the Binding of
UPF2 to UPF1
(A) Cartoon depicting the different branches of the
NMD pathway.
(B) HEK293T cells were cotransfected with the
indicated shRNA constructs and FLAG-UPF1 and
subjected to anti-FLAG IPs. Input (0.5%) and anti-
FLAG IPs (20%) were analyzed by western blotting
with the indicatedantibodies. The right panel shows
the depletion of DHX34 for the input samples. The
lower band represents DHX34. The asterisk above
DHX34 indicates an unspecific band.
(C) HEK293T cells were transfected with an shRNA
targeting DHX34 or with an empty vector control.
After 4 days, cells were cotransfected with FLAG-
UPF1 and an shRNA-resistant (R) T7-DHX34 (wild-
type or the ATPase-deficient mutants K191S or
D279A). Input (0.5%) and anti-FLAG IPs (20%)
were analyzed by western blotting with the indi-
cated antibodies.
(D) Endogenous UPF1 protein complexes were
immunoprecipitated from HEK293T cells depleted
of DHX34. The Immunoprecipitates were probed
for proteins indicated on the left.
(E) Inputs (0.5%) and anti-FLAG IPs (20%) of
cells coexpressing FLAG-UPF1 (wild-type, or the
C126S, LECY181-184VRVD, or VV204-205 mu-
tants) and T7-DHX34 were analyzed for the indi-
cated proteins.of the SURF complex (Figure 4). Importantly, we could not detect
a direct role for DHX34 in the activation of SMG1 (Figure S4),
suggesting a role of DHX34 in promoting a molecular event
that indirectly results in the activation of the SMG1 kinase. It
has been shown that UPF1 phosphorylation requires the interac-
tion of components of the SURF complex with UPF2-UPF3-EJC
downstream of a PTC (Kashima et al., 2006). Indeed, we were
able to show that a major role for DHX34 is to promote the
recruitment of UPF2 to the SURF complex together with the
release of eRF3 (Figures 5 and 6). We propose that DHX34
acts by facilitating UPF1-UPF2 interactions that result in the re-
modeling of the SURF complex, leading to increased UPF1
phosphorylation as a consequence.
Although helicases were first described as ATPases that un-
wind polynucleotide duplexes, several members of the DExH/D
box family function as RNPases that promote ATP-dependent
RNP remodeling by removing proteins from the RNA in the
absence of double-stranded RNA unwinding (Fairman et al.,
2004; Schwer, 2001). For example, crystal structure analysis re-
vealed that the DEAD box protein eIF4A3 binds RNA in an ATP-
dependent fashion and serves as a platform for the nucleation
of the EJC core factors (Andersen et al., 2006; Bono et al.,1852 Cell Reports 8, 1845–1856, September 25, 2014 ª2014 The Authors2006). Once loaded, this DEAD box
RNA helicase can serve as a nucleation
center to recruit additional proteins and
establish a larger ribonucleoprotein com-
plex. We cannot rule out that DHX34
helicase activity is additionally required
to cause strand displacement of second-
ary RNA structure in the vicinity of a PTC.A role for an RNA helicase in remodeling protein-RNA com-
plexes involved in NMD was recently shown, with the ATPase
activity of UPF1 being required to promote the disassembly of
mRNPs undergoing NMD (Franks et al., 2010). This function
can be assisted by another RNA helicase MOV10, which assists
UPF1-mediated mRNA degradation by resolving secondary
structures and displacing proteins from 30 UTRs (Gregersen
et al., 2014).
We have clearly established that the ATPase activity of DHX34
is required to promote UPF2 recruitment to UPF1, to induce
UPF1 phosphorylation and to dissociate the release factors
eRF1/3. All these events are hallmarks of the transition from
the SURF to theDECID complex (Figure 7). It is tempting to spec-
ulate that DHX34 function in NMD relies on its ability to promote
the release of eRF1 and eRF3, preventing translation termination
and allowing the NMD machinery to target faulty mRNAs for
decay. In summary, results presented here highlight the complex
nature of the molecular mechanisms that result in the activation
of NMD. We propose that the DEAH (DExH/D) box RNA helicase
DHX34 remodels NMD complexes in an ATP-driven manner
causing a transition from SURF to the DECID complex that re-




Figure 6. DHX34 Promotes eRF3 Release
from the SURF Complex
(A) FLAG-UPF1 was transiently coexpressed with
T7-DHX34 in HEK293T cells. Inputs (0.5%) and
anti-FLAG IPs (20%) were analyzed with the indi-
cated antibodies.
(B) HEK293T cells were transiently transfected
with FLAG-UPF1 and with an shRNA targeting
DHX34 or with an empty vector control. Inputs
(0.5%) and anti-FLAG (20%) IPs were analyzed by
western blotting for the indicated proteins.
(C and D) Cells were transfected with an shRNA
targeting DHX34 or with an empty vector control.
After 4 days cells were cotransfected with FLAG-
eRF1 (C) or FLAG-eRF3 (D) and shRNA-resistant
(R) T7-DHX34 (wild-type or the ATPase-deficient
mutants K191S and D279A). Anti-FLAG immuno-
precipitations were performed 2 days later and
analyzed for the presence of DHX34. Input (0.5%)
and anti-FLAG IPs (20%) were analyzed by west-
ern blotting with the indicated antibodies.EXPERIMENTAL PROCEDURES
Transfection, Immunoprecipitation, and Western Blot Analysis
For shRNA transfections, cells grown in 6-well plates were transfected with
4 mg of plasmid shRNA pSuperpuro with Lipofectamine 2000 (Life Technolo-
gies) following manufacturer’s instructions and expanded 24 hr later into
selective media containing 0.75 mg Puromycin (Sigma-Aldrich). For rescue
experiments, cells were transfected 72 or 96 hr later with 10 mg of shRNA,
together with 20 mg of pcDNA3 3 FLAG-UPF1, as well as 20 mg of a plasmid
expressing shRNA-resistant wild-type, mutant constructs, or empty vector
controls, selected with medium containing puromycin and harvested for
immunoprecipitation 48 or 72 hr later. For affinity purification, cells were trans-
fectedwith 20 mg of T7-tagged or FLAG-tagged expression vectors. Cells were
washed 48 hr later with 10 ml PBS and lysed in 2 ml IP buffer (10 mM Tris-HCl
[pH 8], 150 mM NaCl, 1 mM EGTA, 1% NP-40, 0.2% Na-Deoxycholate, Com-
plete Protease Inhibitor (Roche), Phospho STOP (Roche), 1 mM DTT). In some
experiments, cell lysates were treated with 40–80 mg/ml RNase A per 1 ml
extract. Protein complexes were analyzed by SDS-PAGE using 3%–8%Cell Reports 8, 1845–1856, SepTris-Acetate or 5%–15% Tris-glycine gels (Life
Technologies) followed by western blotting or
mass spectrometry analysis. For immunoprecipi-
tations of eRFs, cells were lysed in 20 mM Tris-
HCl (pH 7.2), 150 mM KCl, 10 mM MgCl2, 0.5%
NP-40, Complete Protease Inhibitor (Roche Diag-
nostics), Phospho STOP (Roche Diagnostics),
and 1 mM DTT as previously described (Ivanov
et al., 2008). Analysis of peptide samples by nLC-
MS/MS and provision of MASCOT report was
carried out by FingerPrints Proteomics Facility,
University of Dundee. Interactions were consid-
ered as positive if they retained a significant score
after subtracting polypeptides found with the
preimmune serum control.
In Vitro Pull-Down Assays
HEK293T cells were grown in 10 cm plates and
transfected using Lipofectamine 2000 according
to the manufacturer’s protocol. Two days after
transfection, cells were lysed in IP buffer (10 mM
Tris [pH 8], 150 mM NaCl, 1 mM EGTA, 1% NP-
40, 0.2% Na-Deoxycholate, Complete Protease
Inhibitor (Roche), Phospho STOP, 1 mM DTT).After centrifugation for 10 min at 4C, supernatants were incubated immedi-
ately after with anti-FLAG (Sigma) at 4C for 2 hr. Subsequently, the beads
were washed twice with IP buffer, with IP buffer containing 1 M NaCl, with
buffer F (20 mM Tris-HCl [pH 7.5], 1.2 mM EGTA, 250 mM sucrose, 150 mM
NaCl, 1% Triton X-100, 0.5% NP-40), buffer F250 (buffer F, supplemented
with 250 mM LiCl), with buffer D (20 mM HEPES-KOH [pH 7.9], 100 mM KCl,
0.2 mM EDTA, 5% glycerol, 0.5% NP-40, 0.2% Na-Deoxycholate), twice
with buffer D400 (buffer D, supplemented with 400 mM KCl), and finally resus-
pended in buffer D. FLAG-UPF1 full-length protein affinity purification was
performed as described above, and the protein was eluted with IP-buffer sup-
plemented with 1 MNaCl. Recombinant UPF1, UPF2 and UPF3b purified from
E. coli were a gift of Roberto Melero and Oscar Llorca (Madrid). They were
diluted in buffer D and clarified with FLAG-M2 agarose or T7 agarose. The
supernatant was subsequently incubated with FLAG-DHX34 beads, FLAG-
KAT8, FLAG M2, T7-DHX34 (wild-type or deletion constructs), or T7 agarose
beads and incubated for 2 hr at 4C. For pull-down reactions in the presence
of RNases, RNase A was added to 80 mg/ml. The beads were washed twice













UPF3 UPF2 CH SQ
UPF1DHX34 
EJC




































Figure 7. Model Depicting the Role of
DHX34 in NMD Activation
A translation termination event upstream of an
exon junction complex leads to the recruitment of
UPF1 and SMG1 by the eukaryotic translation
release factors eRF1 and eRF3, forming the sur-
veillance complex (SURF). At this stage, UPF1
activity is repressed by two distinct intramolecular
interactions mediated by the N-terminal CH
domain and the C-terminal SQ domain (Chakra-
barti et al., 2011; Fiorini et al., 2013). During the
assembly of the decay-inducing complex (DECID),
the interaction of UPF1 with UPF2 induces a
large conformational change in the regulatory CH
domain of UPF1; however, complete activation is
only achieved when repression of its SQ domain is
relieved and the bound SMG1 kinase phosphory-
lates UPF1 on its SQ domain. This is accompanied
by the displacement of the ribosome and the
eRFs from the RNP complexes. This conversion is
enhanced by DHX34, which associates with the
SURF complex and promotes the remodeling of
the SURF complex. DHX34 triggers the release
of the release factors eRF1 and eRF3 in an ATP-
hydrolysis-dependent manner and promotes the
interaction of UPF1 with UPF2 and additional EJC
proteins and induces the transition to the DECID
complex that targets the RNA for decay.with buffer D. Proteins were eluted with 40 ml protein sample buffer and
analyzed by SDS-PAGE and stained with Colloidal Coomassie (Life Technolo-
gies) and western blotting.
In Situ UV Crosslinking mRNP Capture Assay
In situ UV crosslinking mRNP capture was performed as previously described
(Pin˜ol-Roma and Dreyfuss, 1992). HEK293T cells were transfected with 20 mg
pcDNA3 3 FLAG plasmids per 100 mm dishes. After 48 hr, RNA and protein
complexes were UV crosslinked and scraped from 150 mm plates in 10 ml
cold PBS, pelleted, and lysed for 10 min with 750 ml 10 mM Tris-HCl (pH 7.5),
60 mM NaCl, 5 mM MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 0.2% NP-40, 1 mM
DTT, and minicomplete EDTA-free protease inhibitor (Roche Diagnostics).
Cells were centrifuged, and supernatants were then denatured by the addition
of an equal volumeof 23bindingbuffer (20mMTris-HCl [pH7.5], 1MNaCl, 1%
SDS, 0.2 mM EDTA). Approximately 50 ml packed bed volume of Oligo dT cel-
lulose (Ambion) equilibrated in 1 3 binding buffer was added to each fraction.
The extracts weremixed with oligo dT cellulose overnight at room temperature
ona rotatingwheel andwashed thenext day three timeswith 1ml of 13binding
buffer. Captured mRNPs were eluted from the resin with 400 ml elution buffer
(10mMTris-HCl [pH7.5], 1mMEDTA,minicomplete EDTA-free protease inhib-
itor) and 4 ml of RNase (RocheDiagnostics) for 30min at 37C. LiberatedmRNA
binding proteins were then precipitated by adding an equal volume of 20%
TCA, incubating on ice for 20min and pelleted in a refrigeratedmicrocentrifuge1854 Cell Reports 8, 1845–1856, September 25, 2014 ª2014 The Aufor 20 min at 13,000 rpm. The precipitated proteins were then washed in ice-
cold acetone and resuspended in 40 ml of SDS-PAGE sample buffer. Captured
mRNAbinding proteinswere then resolved by3%–8%NovexTris-Acetate gels
(Life Technologies) SDS-PAGE and analyzed by western blotting.
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